Fortrea Holdings Inc. logo

Fortrea Holdings Inc. (FTRE)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
22. 49
-0.26
-1.1211%
$
1.98B Market Cap
467.67 P/E Ratio
- Div Yield
1.9M Volume
1.12 Eps
$ 22.75
Previous Close
Add Transaction
Day Range
21.86 23.14
Year Range
8.55 23.51
Want to track FTRE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fortrea Holdings Inc. (FTRE) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Fortrea Holdings Inc. (FTRE) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fortrea Holdings Inc. ("Fortrea Holdings Inc.") (NASDAQ:FTRE) concerning possible violations of federal securities laws. Jefferies downgraded Fortrea on September 25, 2024, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding.

Accesswire | 2 years ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ:FTRE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Accesswire | 2 years ago
Fortrea Holdings Inc. Being Investigated on Behalf of Fortrea Holdings Inc. Investors. Contact Levi & Korsinsky For Details.

Fortrea Holdings Inc. Being Investigated on Behalf of Fortrea Holdings Inc. Investors. Contact Levi & Korsinsky For Details.

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fortrea Holdings Inc. ("Fortrea Holdings Inc.") (NASDAQ:FTRE) concerning possible violations of federal securities laws. Jefferies downgraded Fortrea on September 25, 2024, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding.

Accesswire | 2 years ago
ATTENTION Fortrea Holdings Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

ATTENTION Fortrea Holdings Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fortrea Holdings Inc. ("Fortrea Holdings Inc.") (NASDAQ:FTRE) concerning possible violations of federal securities laws. Jefferies downgraded Fortrea on September 25, 2024, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding.

Accesswire | 2 years ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ:FTRE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Accesswire | 2 years ago
An Investigation Has Commenced on Behalf of Fortrea Holdings Inc. Shareholders. Contact Levi & Korsinsky to Discuss your FTRE Losses

An Investigation Has Commenced on Behalf of Fortrea Holdings Inc. Shareholders. Contact Levi & Korsinsky to Discuss your FTRE Losses

NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fortrea Holdings Inc. ("Fortrea Holdings Inc.") (NASDAQ:FTRE) concerning possible violations of federal securities laws. Jefferies downgraded Fortrea on September 25, 2024, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding.

Accesswire | 2 years ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE

NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ:FTRE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Accesswire | 2 years ago
Fortrea Holdings Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - FTRE

Fortrea Holdings Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - FTRE

NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fortrea Holdings Inc. ("Fortrea Holdings Inc.") (NASDAQ:FTRE) concerning possible violations of federal securities laws. Jefferies downgraded Fortrea on September 25, 2024, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding.

Accesswire | 2 years ago
Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings Inc. (FTRE) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings Inc. (FTRE) Shareholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESSWIRE / October 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings Inc. ("Fortrea" or "the Company") (NASDAQ:FTRE). Investors who purchased Fortrea securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FTRE.

Accesswire | 2 years ago
Levi & Korsinsky Reminds Fortrea Holdings Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - FTRE

Levi & Korsinsky Reminds Fortrea Holdings Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - FTRE

NEW YORK, NY / ACCESSWIRE / October 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fortrea Holdings Inc. ("Fortrea Holdings Inc.") (NASDAQ:FTRE) concerning possible violations of federal securities laws. Jefferies downgraded Fortrea on September 25, 2024, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding.

Accesswire | 2 years ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings Inc. (FTRE) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings Inc. (FTRE) And Encourages Shareholders to Connect

NEW YORK CITY, NY / ACCESSWIRE / October 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings Inc. ("Fortrea" or "the Company") (NASDAQ:FTRE). Investors who purchased Fortrea securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FTRE.

Accesswire | 2 years ago
Investors who lost money on Fortrea Holdings Inc. should contact Levi & Korsinsky about an ongoing investigation - FTRE

Investors who lost money on Fortrea Holdings Inc. should contact Levi & Korsinsky about an ongoing investigation - FTRE

NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fortrea Holdings Inc. ("Fortrea Holdings Inc.") (NASDAQ:FTRE) concerning possible violations of federal securities laws. Jefferies downgraded Fortrea on September 25, 2024, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding.

Accesswire | 2 years ago
Loading...
Load More